Case series, chemotherapy-induced cardiomyopathy: mind the family history!

Setareh MoghadasiRienke FijnSaskia L M A BeeresHennie BikkerJan D H JongbloedDjike Josephus JittaJudith R KroepRonald H Lekanne DeprezYvonne J VosMariëlle J M de VreedeM Louisa AntoniDaniela Q C M Barge-Schaapveld

Published in: European heart journal. Case reports (2021)

Current guidelines recommend cardiac evaluation in cancer patients receiving chemotherapy based on the presence of cardiovascular risk factors at the start of treatment. This series emphasizes the importance of including a thorough family history in this process.

Keyphrases

cardiovascular risk factors
chemotherapy induced
cardiovascular disease
papillary thyroid
metabolic syndrome
left ventricular
heart failure
squamous cell
type diabetes
radiation therapy
lymph node metastasis
childhood cancer
smoking cessation
clinical evaluation